Indication
High-risk Stage II Colorectal Cancer
1 clinical trial
2 products
Clinical trial
Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer: A Multicenter, Prospective, Randomized Controlled Cohort Study (FINE Trial)Status: Recruiting, Estimated PCD: 2026-06-01
Product
mFOLFIRINOX